SCHEMBL5866655

SCHEMBL5866655

Cc1cc(COc2ccc(N(CC3(c4n[nH]c(=S)[nH]4)CC3)C(=O)C(F)(F)F)cc2)c2ccccc2n1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 14/20 0.46
MMP13 P45452 6/20 0.46
MMP3 P08254 3/20 0.45
ADAMTS4 O75173 2/20 0.45
MMP8 P22894 2/20 0.45
ADAMTS1 Q9UHI8 2/20 0.45
ADAMTS5 Q9UNA0 2/20 0.45
MMP7 P09237 2/20 0.45
MMP12 P39900 2/20 0.44
MMP10 P09238 1/20 0.43
MMP14 P50281 1/20 0.43
MMP15 P51511 1/20 0.43
MMP2 P08253 3/20 0.42
MMP9 P14780 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5866653 0.82 MMP2 (0.56) ADAM17MMP13MMP3MMP12MMP2
SCHEMBL5250124 0.80 MMP2 (0.61) ADAM17MMP13MMP3MMP12MMP2
SCHEMBL3966360 0.79 ADAM17 (0.54) ADAM17MMP13MMP12MMP2
SCHEMBL5866693 0.78 MMP3 (0.53) ADAM17MMP13MMP3ADAMTS4MMP8
SCHEMBL5866626 0.77 ADAM17 (0.45) ADAM17MMP13MMP7MMP12
SCHEMBL3964733 0.77 MMP2 (0.63) ADAM17MMP13MMP3MMP12MMP2
SCHEMBL6099189 0.76 ADAM17 (0.51) ADAM17MMP13MMP3MMP7MMP12
SCHEMBL5866669 0.75 ADAM17 (0.47) ADAM17MMP13
SCHEMBL5866708 0.75 ADAM17 (0.45) ADAM17MMP13MMP7MMP12
SCHEMBL5866671 0.73 ADAM17 (0.49) ADAM17MMP13MMP3ADAMTS4MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074810-B2 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme BRISTOL-MYERS SQUIBB COMPANY (US) 2006-07-11 US disclosed
US-20040116491-A1 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme BRISTOL-MYERS SQUIBB COMPANY 2004-06-17 US disclosed